Canwell Biotech Limited
4 clinical trials · Sponsor
◉ Watch Canwell Biotech Limited
| Record | Firm | Date |
|---|---|---|
| CW-301 FIH Study of CAN016 (NCT07664150) | Canwell Biotech Limited | 2026-06-18 |
| CAN1012 Combined With PD-1 in Patients With Solid Tumors (NCT06410703) | Canwell Biotech Limited | 2024-06-27 |
| Intratumoral CAN2109 in Subjects With Solid Tumors (NCT06332430) | Canwell Biotech Limited | 2024-05-28 |
| Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors (NCT05580991) | Canwell Biotech Limited | 2022-09-09 |
Track Canwell Biotech Limited automatically
Every clearance here is in the API, with alerts when new ones post.